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Increasing evidence supports a role for cerebrovasculature dysfunction in the etiology
of Alzheimer’s disease (AD). Blood vessels in the brain are composed of a collection of
cells and acellular material that comprise the neurovascular unit (NVU). The NVU in the
hippocampus and cortex receives innervation from cholinergic neurons that originate in
the basal forebrain. Death of these neurons and their nerve fibers is an early feature
of AD. However, the effect of the loss of cholinergic innervation on the NVU is not
well characterized. The purpose of this study was to evaluate the effect of the loss of
cholinergic innervation of components of the NVU at capillaries, arteries and veins in the
hippocampus and cortex. Adult male C57BL/6 mice received an intracerebroventricular
injection of the immunotoxin p75NTR mu-saporin to induce the loss of cholinergic
neurons. Quadruple labeling immunohistochemistry and 3D reconstruction were carried
out to characterize specific points of contact between cholinergic fibers and collagen IV,
smooth muscle cells and astrocyte endfeet. Innate differences were observed between
vessels of the hippocampus and cortex of control mice, including a greater amount
of cholinergic contact with perivascular astrocytes in hippocampal capillaries and a
thicker basement membrane in hippocampal veins. Saporin treatment induced a loss
of cholinergic innervation at the arterial basement membrane and smooth muscle cells
of both the hippocampus and the cortex. In the cortex, there was an additional loss of
innervation at the astrocytic endfeet. The current results suggest that cortical arteries are
more strongly affected by cholinergic denervation than arteries in the hippocampus. This
regional variation may have implications for the etiology of the vascular pathology that
develops in AD.
Keywords: neurovascular unit, cholinergic, Alzheimer’s disease, cerebral amyloid angiopathy, cortex,
hippocampus
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INTRODUCTION
The loss of cholinergic neurons in the basal forebrain and the
areas innervated by their fiber projections is a hallmark of
Alzheimer’s disease (AD; Whitehouse et al., 1982; Francis et al.,
1999). Decreased cholinergic innervation of the hippocampus
and cortex is associated with memory impairment (Damasio
et al., 1985), decreased mini-mental state examination scores and
behavioral changes (Perry, 1980; Tong and Hamel, 1999; Garcia-
Alloza et al., 2005). Moreover, acetylcholinesterase inhibitors
(AChEIs) are currently one of only two approved drugs for
the treatment of AD (Hampel et al., 2018). Recent studies
have demonstrated that loss of basal forebrain gray matter
occurs before the onset of clinical symptoms (Schmitz and
Nathan Spreng, 2016) and that administration of the AChEI
Donepezil during the prodromal stage of AD prevented basal
forebrain degeneration (Cavedo et al., 2017). This highlights the
significance of cholinergic neurotransmission in AD.
Numerous experimental models have been used to mimic
the loss of basal forebrain cholinergic neurons and their fiber
projections. These include injection of ibotenic acid into the
substantia innominata (Vaucher and Hamel, 1995), lesioning of
the fimbria fornix (van der Staay et al., 1989) and electric pulse
ablation of the medial septum (Scheiderer et al., 2006; Nelson
et al., 2014). However, these models can result in widespread
degeneration that may not specifically target cholinergic cell
populations. The discovery that cholinergic neurons in the basal
forebrain express the p75 neurotrophin receptor (NTR), while
other populations of cholinergic neurons do not (Steininger et al.,
1993), allowed for the development of targeted immunotoxins
such as 192 IgG-saporin and its mouse analog, mu-p75-saporin.
In vivo administration of mu-p75-saporin has been shown
to selectively kill cholinergic neurons in the medial septum,
horizontal and diagonal bands of Broca and nucleus basalis of
Meynert and cause withdrawal of cholinergic projections in the
cortex and hippocampus in mice (Berger-Sweeney et al., 2001;
Hunter et al., 2004; Hamlin et al., 2013; Kerbler et al., 2013;
Laursen et al., 2013; Ramos-Rodriguez et al., 2013). Although
recent genetically-driven technologies such as optogenetics
and designer receptor exclusively activated by designer drug
(DREDD) have led to more targeted approaches to silence
specific cholinergic populations (Hangya et al., 2015; Zhang et al.,
2017), it is not clear if these techniques replicate the loss of
cholinergic innervation that is seen in AD.
In addition to early loss of cholinergic neurons, increasing
evidence suggests that alterations of the cerebrovasculature
contribute to the etiology and/or progression of AD. In fact,
vascular pathology has been suggested to be the earliest indicator
of the development of AD (Jack et al., 2010; Iturria-Medina et al.,
2016). The most common form of cerebrovascular pathology
associated with AD is cerebral amyloid angiopathy (CAA). CAA
is defined as the presence of β-amyloid (Aβ) deposits in the
walls of cerebral blood vessels (Vinters, 1987) and is believed to
develop due to an age-related failure of clearance of Aβ from the
brain. CAA develops principally in cortical and leptomeningeal
arteries, with additional capillary involvement in individuals
carrying the apolipoprotein E4 (apoE4) allele (Thal et al., 2008). It
is observed least frequently in veins. Topographically, CAA starts
in blood vessels of neocortical areas (e.g., occipital and parietal
lobe), while subcortical vessels (e.g., hippocampus, thalamus)
are typically not affected until later stages of the disease (Thal
et al., 2008; Vinters and Gilbert, 1983). The reasons underlying
the development of CAA and its pattern of distribution are
currently unknown.
Blood vessels in the brain are composed of endothelial
cells, basement membrane proteins, pericytes, smooth muscle
cells, astrocytes and neurons that are collectively referred to
as the neurovascular unit (NVU; Iadecola, 2017). The NVU
is also a target of cholinergic innervation, which can occur at
multiple sites, including astrocytes, smooth muscle cells and
endothelial cells (Vaucher and Hamel, 1995). This innervation is
important for the maintenance of vascular tone and in mediating
site-directed blood flow via neurovascular coupling (Hamel,
2006). Loss of cholinergic contact with blood vessels has been
reported in the cortex of AD brains (Tong and Hamel, 1999) and
in transgenic mouse models of AD (Kuznetsova and Schliebs,
2013; Michalski et al., 2017). However, most of these studies
have been carried out using 2D images and have focused on
specific brain regions and/or selected vessels. Thus, the impact
of the loss of cholinergic innervation on the entire NVU is not
well characterized.
In this study, the mu-p75-saporin saporin model was used to
induce death of basal forebrain cholinergic neurons and their
fiber projections. Quadruple labeling immunohistochemistry
and 3D reconstruction were carried out to characterize specific
points of contact between cholinergic fibers and various
components of the NVU and to compare this pattern between
the cortex and the hippocampus.
MATERIALS AND METHODS
Animals
Eight- to ten-week-old male C57BL/6 mice were obtained from
The Open University (OU,Milton Keynes, UK) or the University
of Southampton (Southampton, UK) and were kept on a 12 h
light/dark cycle with access to food and water ad libitum.
Experiments were carried out in compliance with guidelines of
the Animal Welfare and Ethics Research Boards at the Open
University and the University of Southampton and with approval
from the Home Office (PPL 70/8507; PPL 30/3095).
Intracerebroventricular Injections
Mice were anesthetized under isoflurane gas and placed into
a stereotaxic frame (Kopf instruments, CA, USA). Topical
anesthetic (Cryogesic, Acorus Therapeutics Limited Chester,
UK) was applied to the scalp before the head was shaved.
A midline incision was made and the skull cleaned. A small
burr hole was drilled over the left and right lateral ventricles
and 0.5 µL of mu-saporin (0.596 µg/µL, Advanced Targeting
Systems, San Diego, CA, USA; n = 16) or 0.9% saline (n = 19)
was injected into each ventricle (coordinates from Bregma:
AP = −0.4 mm, ML = 1.0 mm, DV = −2.3 mm) at a rate
of 0.2 µl/min using a 32G Hamilton syringe. The needle
was left in situ for 2 min after the injection to allow for
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diffusion. Analgesia was administered intraperitoneally at the
time of surgery (Carprieve, 5% w/v, 0.32 ml/kg, Norbrook,
Northamptonshire, UK) and mice were able to self-administer
sugar-free jelly (Hartley, Histon Sweet Spreads Limited, Leeds,
UK) containing Carprofen (250 µg, Zoetis, London, UK) for
1 week post-surgery.
Tissue Processing
All mice were perfused intracardially with 0.01 M phosphate
buffered saline (PBS, pH 7.4) 45 days after surgery. For Western
blots, brains were immediately dissected and snap frozen on dry
ice and stored at −80◦C. For immunohistochemistry, mice were
perfused with 4% paraformaldehyde, the brains were post-fixed
overnight and left in 30% sucrose for 1 week. Brains were
cryosectioned at 20 µm thickness and collected as free-floating
coronal sections and stored in anti-freeze storage solution (30%
glycerol, 30% ethylene glycol, 40% 0.01 M PBS) at−20◦C.
Western Blotting
Tissues from control (n = 8) and saporin-treated mice (n = 6)
were homogenized in Ripa lysis buffer [20 mM Tris-HCl (pH
8.0), 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Igepal,
50 mM NaF, 1 mM NaVO3] containing a protease inhibitor
cocktail (Merck Millipore, Watford, UK), spun down (13,000 g,
10 mins, 4◦C) and supernatants collected, aliquoted and frozen
at −80◦C until further use. Proteins (30 µg) were separated
by gel electrophoresis on 4%–20% Tris-acetate gels (Fisher
Scientific) and transferred onto a nitrocellulose membrane.
Membranes were incubated overnight at 4◦C with anti-choline
acetyltransferase (ChAT, 1:500, Merck Millipore), stripped and
re-probed with anti-glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, 1:50,000, Sigma-Aldrich, Dorset, UK) antibody to
ensure equal protein loading. Two blots were replicated for each
brain region. Immunoblotswerequantifiedbydensitometryusing
ImageJ software (NIH, MD, USA) and calculated as an optical
density ratio of protein levels normalized to GAPDH levels.
Immunohistochemistry
For single-labeling immunohistochemistry of cholinergic cell
bodies and fibers, tissue sections were washed in 0.01 M PBS,
blocked with 15% normal donkey serum (NDS; Sigma-Aldrich)
and incubated overnight with either anti-ChAT (1:100) or
anti-laminin (1:350, Sigma-Aldrich), after pre-treatment with
pepsin (1 mg/mL in 0.2 N HCl, 30 s at 37◦C). The next day,
sections were washed in PBS and incubated for 2 h at room
temperature with anti-donkey AlexaFluor 488 (Fisher Scientific,
Loughborough, UK). For quadruple labeling of the NVU,
sections were treated with pepsin, incubated overnight with
anti-ChAT (1:100), washed in PBS and incubated with anti-goat
AlexaFluor 555. After washing in PBS, sections were incubated
simultaneously with anti-collagen IV (1:100, Abcam, Cambridge,
UK), anti-α smooth muscle actin (α-SMA)-FITC (1:350, Sigma-
Aldrich) and anti-glial fibrillary protein (GFAP, 1:500, Abcam).
Sections were then developed with anti-rabbit AlexaFluor
405 and anti-chicken AlexaFluor 633 (1:200, Fisher Scientific).
All fluorescent sections were coverslipped using Mowiolr
(Sigma-Aldrich) containing 0.1% v/v Citifluor (Citifluor Limited,
London, UK) mounting media.
Image Acquisition and Analysis
Coronal brain sections were imaged with an SP5 Leica scanning
laser confocal microscope. Low magnification images of the
cortex and hippocampus were stitched together using ImageJ
software (NIH, MD, USA). The density of neuronal cell
bodies, fibers and blood vessels in each region of interest was
quantified by calculating the percentage area covered by staining
using ImageJ software. NVUs in the hippocampus and cortex
were imaged using the ×100 oil immersion objective, using
z stacks with ≤2 µm spacing between slices. Images were
deconvolved and converted into Imaris-compatible files using
AutoQuant X3 version X3.0.4 software (MediaCybernetics Inc.,
Rockville, MD, USA).
3D Reconstruction of the NVU
To quantify the parameters of each component of the NVU,
deconvolved images were processed using Imaris software
(Bitplaner) and surfaces were created for each component
of the NVU. For each vessel, the following measurements
were acquired: the total area of a selected surface (µm2),
the volume of a selected surface (µm3), the length of the
vessel imaged (µm) and the average diameter of the vessel
(µm). The total area of contact between two selected surfaces
(e.g., ChAT nerve fibers contacting collagen IV) was calculated
using the Imaris Xtension ‘‘Surface to Surface Contact Area’’
(Imaris V8.31, ImarisXT Bitplane Inc created by Matthew J
Gastinger, Bitplane). Only surfaces that made direct contact
with each other (i.e., 0 µm apart) were quantified. Vessels
were classified as capillaries if they were ≤10 µm in diameter,
arteries were identified as having a diameter of >10 µm
and positive for SMA, while veins were identified as having
a diameter >10 µm but lacking SMA. A total of five
capillaries, five arteries and three veins were quantified for
each mouse (n = 7–11 control, n = 6–10 saporin) per brain
region and the average values per mouse were used for
statistical analysis.
Statistical Analysis
Data were tested for normality using the Kolmogorov-Smirnov
test. For normally distributed data, comparisons between two
groups were carried out using two-tailed Student’s t-test. Where
there were more than two groups, one-way or two-way repeated
measures ANOVA was used followed by Sidak’s post hoc. The
ROUT test was used to identify and exclude any outliers. For
data that were not normally distributed, the Mann-Whitney U
test or Kruskal-Wallis test with Dunn’s post hoc test was used.
Data represents mean± SEM and p< 0.05 was considered to be
statistically significant. Analysis was carried out using GraphPad
Prism software.
RESULTS
Cholinergic Loss in the Medial Septum,
Hippocampus and Cortex Following
Administration of Mu-Saporin
As shown in Figure 1, ChAT-positive cholinergic neurons
were observed in the medial septum, diagonal band of Broca,
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FIGURE 1 | Loss of cholinergic neurons and fiber projections following administration of mu-p75-saporin. (A–H) Photomicrographs of choline acetyltransferase
(ChAT)-positive neurons and fibers in the medial septum (A,E), hippocampus (B,F), cortex (C,G) and striatum (E,H) in control (A–D) and saporin-treated (E–H) mice.
(I–L) Quantification of the percent area covered by ChAT-positive staining in control and saporin-treated mice in the medial septum (I), hippocampus (J) and cortex
(K). p75-negative cholinergic neurons in the striatum were not affected by saporin treatment (L). (M–O) Western blotting confirmed a significant loss of ChAT protein
expression in the hippocampus (M) and cortex (N) after saporin administration, while ChAT levels in the striatum did not differ between control and treated mice (O).
Data represent mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, two-tailed Student’s t-test. Scale bar = 100 µm.
nucleus basalis of Meynert and in the striatum of control
mice. Cholinergic fiber projections were also observed in the
hippocampus (Figure 1B) and cortex (Figure 1C). Significantly
less ChAT staining was detected in the medial septum of saporin-
treated mice at 45 days post-surgery (Figures 1E,I). This was
accompanied by a significant decrease in cholinergic nerve
fiber density in the hippocampus (Figures 1F,J) and the cortex
(Figures 1G,K). As expected, p75 NTR-negative neurons in the
striatum were not affected by saporin treatment (Figures 1H,L).
Western blotting confirmed a significant decrease in ChAT
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FIGURE 2 | 3D reconstruction of the neurovascular unit (NVU). (A,B) Photomicrograph (A) and 3D reconstruction (B) of an artery stained for collagen IV (dark blue),
smooth muscle actin (SMA; green), astrocytes (turquoise) and cholinergic nerve fibers (red). (C–E) Yellow outlines indicate the surfaces created for each of the NVU
components. Examples are shown for surface area contact between perivascular astrocytes and collagen IV (C), contact of cholinergic nerve fibers to smooth
muscle cells (D, yellow outlines in inset) and contact of cholinergic nerve fibers to collagen IV (E, yellow outlines in inset). Scale bar (A,B,D,E) = 5 µm, (C) = 20 µm.
protein levels in the hippocampus (Figure 1M) and cortex
(Figure 1N) following saporin administration and no difference
in ChAT expression between control and saporin-treated mice in
the striatum (Figure 1O).
Characterization of Cholinergic Loss at the
NVU in the Hippocampus and Cortex
Cholinergic nerve fibers are known to innervate blood vessels
in the hippocampus and cortex (Vaucher and Hamel, 1995). To
characterize the precise effects of saporin treatment at the NVU,
quadruple-labeling immunohistochemistry was used to label
cholinergic fibers and three components of the NVU—collagen
IV-positive basement membranes, smooth muscle cells and
astrocytes (Figure 2A). Confocal images of the vessels were
then reconstructed using 3D modeling software and surfaces
were created for each of the four proteins (Figures 2B–E). The
surface area of ChAT contact with each component of the NVU
(standardized to vessel length) was analyzed across capillaries,
arteries/arterioles and veins/venules from control and saporin-
treated mice.
At the basement membrane of vessels in the hippocampus,
saporin treatment induced a decrease in the amount of contact
between cholinergic nerve fibers and collagen IV at capillaries,
arteries and veins (Figures 3A–F), although this decrease was
only statistically significant at arteries (Figure 3G). In the cortex,
cholinergic innervation of the basement membrane did not
differ between control and saporin-treated mice at capillaries
and veins but was significantly decreased at the arteries of
saporin-treated mice (Figures 3H–N). No differences were noted
between control and saporin-treated mice at any vessel type in
the striatum (Supplementary Figure S1A).
Analysis of perivascular innervation at the smooth muscles
of arteries found that there was a significant decrease in the
surface area contact between ChAT and α-SMA in saporin-
treated in both the hippocampus (Figures 4A–C) and the
cortex (Figures 4D–F), while the striatum was not affected
(Supplementary Figure S1B).
Quantification of ChAT contact with perivascular astrocytes
in the hippocampus revealed no difference in the amount
of contact with GFAP-positive astrocytes between control
and saporin-treated mice in any vessel type (Figures 5A–G).
By contrast, significantly less ChAT contact was observed
at arteries in the cortex of saporin-treated mice compared
to control animals (Figures 5H–N). No differences were
Frontiers in Aging Neuroscience | www.frontiersin.org 5 July 2019 | Volume 11 | Article 172
Nizari et al. Cholinergic Denervation at the NVU
FIGURE 3 | Perivascular cholinergic contact at the basement membrane. (A–M) Representative images of the 3D reconstruction of the NVU in capillaries (A,B,H,I),
arteries (C,D,J,K) and veins (E,F,L,M) in the hippocampus (A–F) and cortex (H–M) of control (A,C,E,H,J,L) and saporin-treated mice (B,D,F,I,K,M). ChAT-positive
fibers are shown in red, collagen IV is shown in blue and SMA is shown in green. (G,N) Quantification of the surface area of contact between ChAT-positive fibers and
collagen IV demonstrated a significant decrease in contact at the arteries of saporin-treated animals in both the hippocampus (G) and cortex (N). Data represent
mean ± SEM. ∗p < 0.05, two-way ANOVA with Sidak’s post hoc test. Scale bars = 20 µm.
observed between control and saporin mice at cortical
capillaries or veins (Figures 5H–N) or between control
and saporin-treated mice at any vessel type in the striatum
(Supplementary Figure S1C).
To determine if saporin induced changes in blood vessel
density, the percent area covered by laminin-positive capillaries
and large-diameter vessels were quantified in the cortex
and hippocampus of control and saporin-treated mice
(Figures 6A–E). In control mice, the density of both capillaries
and arteries/veins was significantly higher in the cortex
compared to the hippocampus (Figures 6A,B). No differences in
vessel density were noted between control and saporin-treated
mice in either brain region (Figure 6E).
Regional Variation in Perivascular
Innervation
To determine if there were regional differences in endogeneous
and saporin-induced cholinergic innervation, measurements of
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FIGURE 4 | Perivascular cholinergic contact at smooth muscle cells. (A–E) Representative images of the 3D reconstruction of the NVU in arteries in the
hippocampus (A,B) and cortex (D,E) from control (A,D) and saporin-treated (B,E) mice. ChAT-positive nerve fibers are shown in red and smooth muscle cells are
shown in green. (C,F) Quantification of the surface area of contact between ChAT-positive fibers and SMA demonstrated a significant decrease in contact in
saporin-treated animals in both the hippocampus (C) and cortex (F). Data represent mean ± SEM. ∗p < 0.05, Mann-Whitney U test (hippocampus) and one-tailed
Student’s t-test (cortex). Scale bars = 20 µm.
ChAT contact with components of the NVU were compared
between the hippocampus and cortex. Quantification of overall
cholinergic nerve fiber density was found to be significantly
higher in the hippocampus compared to the cortex in control
mice (Figure 7A). Following saporin treatment, this difference
was lost (Figure 7B). The degree of cholinergic innervation at
the basement membrane did not differ between the hippocampus
and cortex at capillaries, arteries or veins of control (Figure 7C)
or saporin-treated mice (Figure 7D). ChAT innervation of
smooth muscle cells also did not differ between arteries in the
hippocampus and cortex in either control (Figure 7E) or saporin-
treated mice (Figure 7F). However, perivascular astrocyte
endfeet surrounding cortical capillaries in control mice received
significantly less cholinergic input compared to astrocytes at the
capillaries in the hippocampus (Figure 7G). Significantly less
cholinergic input onto astrocyte endfeet was also noted at veins
in the cortex of saporin-treated mice compared to hippocampal
veins (Figure 7H).
Impact of Loss of Perivascular Innervation
on Components of the NVU
To determine if loss of cholinergic innervation induced changes
in components of the NVU, the volume of collagen IV and
smooth muscle cells as well as the area of astrocyte endfoot
coverage was evaluated in vessels of control and saporin-treated
mice. Comparisons between the cortex and hippocampus were
also carried out.
As shown in Table 1, within the hippocampus, the volume
of collagen IV was significantly higher in veins compared to
capillaries in control mice. This relationship was maintained
following saporin treatment. However, collagen IV volumes did
not differ between control and saporin-treated mice in any vessel
type. In the cortex, the volume of collagen IV was highest in
arteries compared to capillaries and veins in both control and
saporin-treated mice (Table 1). Regional comparisons including
the striatum revealed that the volume of collagen IV was
significantly higher in veins in the hippocampus than veins in
the cortex and striatum in both control mice and those treated
with saporin.
Analysis of smooth muscle volume found no significant
difference between control and saporin mice in any brain region
(Table 2). Similarly, no significant differences in smooth muscle
volume were noted between the cortex, hippocampus or striatum
in either treatment group (Table 2).
Finally, analysis of perivascular astrocyte coverage of
hippocampal vessels revealed a significantly higher amount of
endfoot contact in veins compared to capillaries in control
animals (Table 3). Following saporin administration, astrocyte
coverage remained significantly higher in hippocampal veins
compared to both capillaries. No differences in perivascular
astrocyte coverage were noted between vessel types in the
cortex in either control or saporin-treated mice (Table 3).
Comparison between vessels of the hippocampus, cortex and
striatum found that astrocyte contact was lowest in all the
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FIGURE 5 | Perivascular cholinergic contact at perivascular astrocytes. (A–M) Representative images of the 3D reconstruction of the NVU in capillaries (A,B,H,I),
arteries (C,D,J,K) and veins (E,F,L,M) in the hippocampus (A–F) and cortex (H–M) of control (A,C,E,H,J,L) and saporin-treated mice (B,D,F,I,K,M). ChAT-positive
fibers are shown in red, collagen IV is shown in blue, SMA is shown in green and glial fibrillary protein (GFAP) is shown in turquoise. (G,N) Quantification of the
surface area of contact between ChAT-positive fibers and astrocyte endfeet found no differences between control and saporin-treated animals in any vessels of the
hippocampus (G), but a significant decrease in contact at the arteries of saporin-treated animals the cortex (N). Data represent mean ± SEM. ∗∗p < 0.01, two-way
ANOVA with Sidak’s post hoc test. Scale bars = 20 µm.
vessel types in the striatum. In addition, astrocyte coverage of
veins in the hippocampus was approximately 10-fold higher
compared to coverage of veins in the cortex and 100-fold
higher than veins in the striatum in both control and saporin
mice (Table 3).
DISCUSSION
Although the loss of cholinergic neurons in AD has been
described extensively, the effect of this loss on the NVU is
not well characterized. Moreover, previous studies that have
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FIGURE 6 | Regional comparison of blood vessel density. (A–D) Photomicrographs of laminin-positive blood vessels in the hippocampus (A,C) and cortex (B,D) of
control (A,B) and saporin-treated mice (C,D). (E) Quantification of the density of capillaries (caps) and large-diameter vessels in the hippocampus and cortex in
treatment groups. Data represent mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, two-tailed Student’s t-test. Scale bar = 100 µm.
looked at perivascular innervation by cholinergic nerve fibers
have largely been carried out using 2D images obtained
from double or triple labeling immunohistochemistry or by
immuno-EM (Itakura et al., 1977; Tong and Hamel, 1999;
Kuznetsova and Schliebs, 2013). By combining quadruple
labeling immunohistochemistry with 3D reconstruction, the
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FIGURE 7 | Regional comparison of measures of the NVU. (A,B) Total
density of ChAT-positive fibers in the cortex and hippocampus in control mice
(A) and following administration of saporin (B). (C–H) Quantification of area of
contact between ChAT-positive fibers and collagen IV (C,D), SMA (E,F) and
astrocyte endfeet (G,H) in the cortex and hippocampus in control (C,E,G)
and saporin-treated mice (D,F,H). Data represent mean ± SEM. ∗p < 0.05,
paired two-tailed Student’s t-test (A,B), Kruskal-Wallis with Dunn’s post hoc
test, (C,D), Wilcoxon matched paired test (E–H).
current study allowed not only for individual components of
the NVU to be assessed under basal and pathological conditions
but also for perivascular innervation to be quantified along
multiple components of the NVU around the entire surface of
the blood vessel.
We chose to use the saporin model of cholinergic denervation
because of its well characterized ability to cause selective death
of basal forebrain cholinergic neurons across many species,
including mice, rats and non-human primates (Fine et al., 1997;
Leanza, 1998; Lin et al., 1999; Berger-Sweeney et al., 2001;
Lehmann et al., 2002; Birthelmer et al., 2003; Hawkes et al.,
2005; Scheiderer et al., 2006; Ramos-Rodriguez et al., 2013).
Such immunotoxin models are preferable to older lesioning
models that can result in widespread, non-specific neuronal
damage (van der Staay et al., 1989; Scheiderer et al., 2006;
Nelson et al., 2014). On the other hand, the relatively rapid
time course of death induced by saporin is unlikely to mimic
the progressive loss of cholinergic neurons that is seen in AD.
More refined methods have been developed to silence basal
forebrain cholinergic neurons using optogenetics and DREDD TA
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technologies (Shi et al., 2015; Chen et al., 2016). However,
whether such techniques fully replicate the loss of cholinergic
signaling, including withdrawal of trophic support and related
inflammatory processes, that is observed in AD is not yet known.
In the present study, administration of saporin led to a significant
and specific loss of cholinergic neurons in the basal forebrain at
45 days post-surgery. The fiber projections from these neurons
were also lost in the hippocampus and cortex. Other major
populations of cholinergic neurons that do not express the
p75NTR, including those in the striatum (Yeo et al., 1997) were
not affected by saporin treatment.
Using 3D reconstruction of blood vessels, ChAT-positive
fibers were found to innervate capillaries, arteries and veins in the
hippocampus and cortex. As expected (Toribatake et al., 1997;
Mulligan and MacVicar, 2004; Hamel, 2006; Hamilton et al.,
2010; Chen et al., 2014), cholinergic innervation was observed
at all levels of the NVU investigated, including the basement
membranes, smooth muscle cells and perivascular astrocytes.
The majority of the innervation was observed at arteries, in
agreement with previous studies (Chédotal et al., 1994; Vaucher
and Hamel, 1995; Luiten et al., 1996; Kuznetsova and Schliebs,
2013). Predominant targeting of arteries by cholinergic nerve
fibers is perhaps unsurprising given the role of ACh in mediating
neurovascular coupling (Hamel, 2006; Willis et al., 2006; Lecrux
et al., 2017).
Increasing evidence suggests that there is heterogeneity of
cells of the NVU, including pericytes and astrocytes, across
both vessel type and brain regions (Shepro and Morel, 1993;
Noumbissi et al., 2018). In the present study, we observed
innate differences between vessels of the hippocampus and
cortex. These included: (i) a significantly higher vessel density
in the cortex; (ii) a higher overall ChAT fiber density in
the hippocampus and more ChAT contact with perivascular
astrocytes in hippocampal capillaries; (iii) thicker basement
membrane in the veins of the hippocampus; and (iv) greater
coverage of the basement membrane by astrocyte endfeet in
hippocampal veins compared to veins in the cortex.
The observation that total cholinergic fiber density was
higher in the hippocampus compared to the cortex is in
agreement with previous reports (Kitt et al., 1994). However,
given that vesssel density showed the opposite pattern, it is
perhaps surprising that there was no difference in the amount
of cholinergic innervation at blood vessels in the hippocampus
vs. those in the cortex. It is possible that by only quantifying
direct contact (e.g., 0 µm distance) between ChAT fibers
and basement membrane or smooth muscle cells, we have
underestimated the potential degree of cholinergic innervation
at the NVU, which has been classified in previous studies
to be within 3 µm from the basement membrane (Vaucher
TABLE 2 | Regional comparison of volume of smooth muscle cells in arteries.
SMA Volume/length
(µm3/µm) ± SEM
Hippocampus Cortex Striatum
Control 60.02 ± 10.6 50.75 ± 16.2 65.88 ± 19.7
Saporin 33.10 ± 7.4 39.54 ± 9.0 33.03 ± 5.7
Values represent mean ± SEM. No significant differences were noted (two-way repeated
measures ANOVA with Sidak’s post hoc test). T
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and Hamel, 1995). Our findings that cholinergic contact with
perivascular astrocyte endfeet tended to be higher in the
hippocampus across all vessel types and was significantly higher
at hippocampal capillaries compared to cortical capillaries,
suggest that there may be functional differences between
cortical and hippocampal vessels in their responsiveness to
cholinergic signaling.
Astrocyte coverage of vessels was also observed to be higher
in the hippocampus than the cortex, although this was only
significant at veins. This is in keeping with the reported
distribution of parenchymal GFAP-positive astrocytes (Emsley
and Macklis, 2006). This finding was likely related to the
observed greater thickness of collagen IV, given that astrocytes
and endothelial cells are the main sites of basement membrane
production (Baeten and Akassoglou, 2011). Expression of
collagen IV has been shown to be significantly upregulated
in capillaries and arteries during normal and in AD (Kalaria
and Pax, 1995; Farkas and Luiten, 2001; Christov et al., 2008;
Magaki et al., 2018). Thickening of the basement membrane
and alterations in basement membrane composition has been
hypothesized to precede the development of CAA (Wyss-Coray
et al., 2000). However, veins are the vessel type least likely
to be affected by CAA and CAA develops more slowly in
vessels in the hippocampus than those in the cortex (Thal
et al., 2008). It may be that increased basement thickness
makes the veins in the hippocampus less likely to be deformed
by pressure changes and thus helps to ensure a consistent
cerebral perfusion (Zócalo et al., 2013; Thorin-Trescases et al.,
2018) and to maintain a driving force for clearance of
solutes in the cerebral spinal fluid (CSF) and/or interstitial
fluid (ISF). In addition, the walls of veins are important
for the egress of leukocytes from the blood into the brain
in neurodegenerative diseases and this process requires that
leukocytes enter a perivenular space bounded by endothelial
and glia limitans basement membranes (Owens et al., 2008;
Engelhardt et al., 2016). The variation in the degree of collagen
IV and astrocyte coverage may reflect regional variability in the
neuroinflammatory properties of the veins in the hippocampus
compared to the cortex.
Saporin treatment significantly reduced the amount of
cholinergic contact with the basement membrane of arteries in
both the cortex and hippocampus, while capillaries and veins
were unaffected. This may reflect the proportional endogeneous
degree of cholinergic innervation between vessel types, which
was highest in arteries. Regional differences were also observed
in the degree of cholinergic loss at the NVU. While saporin
treatment induced a loss of cholinergic innervation at the
basement membrane and smooth muscle cells of arteries in
both the hippocampus and cortex, there was additional loss
of cholinergic contact of astrocyte endfeet in cortical arteries.
The reason for this variability is unknown. It may be that
cholinergic supply of the cortical astrocytes is important for
their function in the convective influx/glymphatic entry of
CSF along the pial glial basement membranes (Albargothy
et al., 2018). Recent 3D mapping studies have shown that
the dendritic arbors of basal forebrain neurons that project to
the cortex differ from those that project to the hippocampus
in that single cortical dendrites innervate large areas of the
neuropil (Wu et al., 2014; Li et al., 2018). It is possible
that a similar pattern of innervation exists at blood vessels
in the cortex such that the loss of one dendritic arbor
affects multiple vessels. This may also be related to the lower
endogeneous level of contact between cholinergic nerves and
astrocytes in the cortex, which may make cortical vessels
more susceptible than those in the hippocampus to loss of
cholinergic innervation.
Each of the NVU components studied have been shown to
play a role in mediating the clearance of Aβ from the brain.
Cerebrovascular basement membranes act as conduits along
which Aβ contained within CSF and ISF is removed from
the brain (Iliff et al., 2012; Hawkes et al., 2013; Morris et al.,
2014; Albargothy et al., 2018). Smooth muscle cells express
low-density receptor related protein-1 (LRP-1) which mediates
cellular uptake of Aβ and its transcytosis across the blood
brain barrier (BBB; Kanekiyo et al., 2012). Moreover, localized
contraction of smooth muscles has recently been proposed to
generate the force that drives intramural periarterial drainage of
Aβ (Aldea et al., 2019). Astrocytes contribute to the formation
of the basement membrane and have also been shown to take
up Aβ via LRP-1 (Basak et al., 2012). In addition, astrocytes
are the main producers of apolipoprotein E, which chaperones
Aβ across the BBB (Bell et al., 2007). Therefore, it is possible
that the combined loss of cholinergic innervation at each of
these components contributes to the increased susceptibility of
cortical vessels to the development of CAA. Further studies
are needed to investigate this putative relationship in human
brain tissues.
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